LIGAND REGULATED PROTEIN-PROTEIN INTERACTION SYSTEM
申请人:St. Anna Kinderkrebsforschung
公开号:EP3502130A1
公开(公告)日:2019-06-26
Disclosed is a ligand regulated protein-protein interaction system based on a lipocalin-fold molecule comprising:
(a) a lipocalin-fold molecule
(b) a lipocalin-fold ligand with a low molecular weight of 1500 Da or below, and
(c) a lipocalin-fold binding interaction partner,
wherein the lipocalin-fold molecule can bind to the lipocalin-fold ligand; and
wherein the lipocalin-fold molecule bound to the lipocalin-fold ligand binds to the lipocalin-fold binding interaction partner with an affinity which is at least 10-fold higher than the affinity of the lipocalin-fold molecule not bound to the lipocalin-fold ligand,
and wherein the lipocalin-fold binding interaction partner is not a naturally occurring protein which has an affinity of <10 µM to any naturally occurring lipocalin-fold molecule in the presence of any lipocalin-fold ligand.
A group of chimeric antigen receptors (CARs) having two, three or four CAR molecules,
wherein the members of the group of CARs can be different in their amino acid sequences, and
wherein each of the CAR molecules of the group includes at least a transmembrane domain and an ectodomain comprising either an antigen binding moiety or a binding site to which another polypeptide is able to bind, wherein the polypeptide comprises an antigen binding moiety;
wherein each CAR molecule of the group includes at least one dimerization domain, wherein this dimerization of a pair of dimerization domains is either induced by a regulating molecule and optionally reduced by another regulating molecule, or occurs in the absence of a regulating molecule and is reduced by a regulating molecule, and
wherein the antigen binding moieties of the CAR molecules of the group specific for one target antigen.
Antus, Sandor; Gottsegen, Agnes; Kolonits, Pal, Liebigs Annalen der Chemie, 1986, # 12, p. 2179 - 2181